Delivery: Promising Immunotherapy Shows Potential for Prostate Cancer Treatment
A phase I trial of the new immunotherapy VIR-5500 reveals that nearly half of participants experienced tumor reduction, with most reporting mild side effects. This innovative treatment could revolutionize care…